These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 21541616)

  • 21. A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li-Fraumeni patients carrying a mutation to the TP53 gene.
    Varley JM; Thorncroft M; McGown G; Appleby J; Kelsey AM; Tricker KJ; Evans DG; Birch JM
    Oncogene; 1997 Feb; 14(7):865-71. PubMed ID: 9047394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas.
    Choi C; Cho S; Horikawa I; Berchuck A; Wang N; Cedrone E; Jhung SW; Lee JB; Kerr J; Chenevix-Trench G; Kim S; Barrett JC; Koi M
    Genes Chromosomes Cancer; 1997 Nov; 20(3):234-42. PubMed ID: 9365830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allelic loss at TP53 is not related to p53 protein overexpression in primary human endometrial carcinomas.
    Semczuk A; Marzec B; Skomra D; Roessner A; Cybulski M; Rechberger T; Schneider-Stock R
    Oncology; 2005; 69(4):317-25. PubMed ID: 16293976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromosomal deletions occur in restricted regions of 5q in testicular germ cell cancer.
    Peng HQ; Liu L; Goss PE; Bailey D; Hogg D
    Oncogene; 1999 May; 18(21):3277-83. PubMed ID: 10359533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21.
    Tavassoli M; Steingrimsdottir H; Pierce E; Jiang X; Alagoz M; Farzaneh F; Campbell IG
    Br J Cancer; 1996 Jul; 74(1):115-9. PubMed ID: 8679443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allelic imbalance on chromosomes 13 and 17 and mutation analysis of BRCA1 and BRCA2 genes in monozygotic twins concordant for breast cancer.
    Försti A; Luo L; Vorechovsky I; Söderberg M; Lichtenstein P; Hemminki K
    Carcinogenesis; 2001 Jan; 22(1):27-33. PubMed ID: 11159737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53.
    Werness BA; Parvatiyar P; Ramus SJ; Whittemore AS; Garlinghouse-Jones K; Oakley-Girvan I; DiCioccio RA; Wiest J; Tsukada Y; Ponder BA; Piver MS
    J Natl Cancer Inst; 2000 Jul; 92(13):1088-91. PubMed ID: 10880552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five distinct deleted regions on chromosome 17 defining different subsets of human primary breast tumors.
    Nagai MA; Medeiros AC; Brentani MM; Brentani RR; Marques LA; Mazoyer S; Mulligan LM
    Oncology; 1995; 52(6):448-53. PubMed ID: 7478429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients.
    Nagai MA; Pacheco MM; Brentani MM; Marques LA; Brentani RR; Ponder BA; Mulligan LM
    Br J Cancer; 1994 Apr; 69(4):754-8. PubMed ID: 7908218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriers.
    Eiriksdottir G; Barkardottir RB; Agnarsson BA; Johannesdottir G; Olafsdottir K; Egilsson V; Ingvarsson S
    Oncogene; 1998 Jan; 16(1):21-6. PubMed ID: 9467939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allelic loss on chromosome 10q in human lung cancer: association with tumour progression and metastatic phenotype.
    Petersen S; Wolf G; Bockmühl U; Gellert K; Dietel M; Petersen I
    Br J Cancer; 1998; 77(2):270-6. PubMed ID: 9460998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletion mapping implicates two tumor suppressor genes on chromosome 8p in the development of bladder cancer.
    Takle LA; Knowles MA
    Oncogene; 1996 Mar; 12(5):1083-7. PubMed ID: 8649800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer.
    van den Berg J; Johannsson O; Håkansson S; Olsson H; Borg A
    Br J Cancer; 1996 Nov; 74(10):1615-9. PubMed ID: 8932343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allele loss from large regions of chromosome 17 is common only in certain histological subtypes of ovarian carcinomas.
    Papp J; Csokay B; Bosze P; Zalay Z; Toth J; Ponder B; Olah E
    Br J Cancer; 1996 Nov; 74(10):1592-7. PubMed ID: 8932340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microsatellite instability and loss of heterozygosity in primary breast tumours.
    Sourvinos G; Kiaris H; Tsikkinis A; Vassilaros S; Spandidos DA
    Tumour Biol; 1997; 18(3):157-66. PubMed ID: 9143412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast tumors.
    Johannsdottir HK; Jonsson G; Johannesdottir G; Agnarsson BA; Eerola H; Arason A; Heikkila P; Egilsson V; Olsson H; Johannsson OT; Nevanlinna H; Borg A; Barkardottir RB
    Int J Cancer; 2006 Sep; 119(5):1052-60. PubMed ID: 16570289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p.
    Beghelli S; Pelosi G; Zamboni G; Falconi M; Iacono C; Bordi C; Scarpa A
    J Pathol; 1998 Sep; 186(1):41-50. PubMed ID: 9875139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Loss of heterozygosity fine mapping of chromosome 17p13 in transitional cell carcinoma of human urinary bladder].
    Zheng S; Zhang J; Di X; Xiao Z; Wang D; Li C; He Z; Han N; Guo S; Cheng S; Gao Y
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):161-3. PubMed ID: 11953150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma.
    Foulkes WD; Ragoussis J; Stamp GW; Allan GJ; Trowsdale J
    Br J Cancer; 1993 Mar; 67(3):551-9. PubMed ID: 8094976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.